Table 2

Characteristics of infections causing VAP during the sustained period of “getting to zero” VAP prevention program
N Year Age Gender Diagnostic MV time (days) Respiratory specimen Pathogen Clinical outcome
1 2009 85 Male DLOC/Hyponatremia 16 Tracheal aspirate P.aeruginosa Death
2 2009 65 Female Hypereosinophilia/ Myelopathy 5 BAL + Tracheal aspirate Acinetobacter baumannii Death
3 2009 20 Male Correction of GERD 19 Tracheal aspirate P.aeruginosa Death
4 2009 23 Female Liver failure/ liver transplant 5 Tracheal aspirate Acinetobacter lwoffii Death
5 2010 56 Male Respiratory failure/ BCP 16 Tracheal aspirate P.aeruginosa Death
6 2010 62 Male Carotid stenosis/ Endarterectomy 8 Tracheal aspirate S.marcescens Hospital discharge
7 2010 59 Male Chagas cardiomyopathy 10 Tracheal aspirate E.cloacae Death
8 2010 55 Female Hepatic encephalopathy 8 Nasopharyngeal swab RSV Death
9 2010 61 Male Acute respiratory failure/ BCP 33 Tracheal aspirate K.pneumoniae + P.aeruginosa Death
10 2010 58 Male Cranial trauma 7 Tracheal aspirate E.aerogenes + A.baumannii Death

MV Mechanical Ventilation.

DLOC Decreased Level Of Consciousness.

GERD Gastroenteral Reflux Disease.

RSV Respiratory Syncytial Virus.

BCP Bronchopneumonia.

BAL Bronchoalveolar lavage.

Caserta et al.

Caserta et al. BMC Infectious Diseases 2012 12:234   doi:10.1186/1471-2334-12-234

Open Data